Used in pharmaceutical research as a key intermediate in the synthesis of selective kinase inhibitors, particularly for targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors and hematological malignancies. Also employed in the study of central nervous system disorders due to its ability to cross the blood-brain barrier. Its structure supports optimization of drug candidates with improved metabolic stability and binding affinity.